FoundersX Superstars

?? WORLD-WIDE ANNOUNCEMENT: AlphaCopilot? Beta 1.0: Pioneering Human-AI Partnership in Investment Management ?? Linvest21, Inc proudly unveils?AlphaCopilot? Beta 1.0, the industry's?first end-to-end agentic investment platform?designed to transform institutional investing and wealth management. Seamlessly integrating human judgment with cutting-edge AI, AlphaCopilot? delivers exceptional results across the investment lifecycle. Based on observation from Pilot Program,?AlphaCopilot??sees up-to: ?? 49% improvement?in research efficiency ?? 42% enhancement?in portfolio construction ?? 45% greater?risk management effectiveness ?? 30% acceleration?in performance analysis ?? 70% streamlined?customized client reporting ?? 65% elevated?market readiness for investment teams ?? 24/7 continuous monitoring?of ~100,000 securities ?? 55% reduction?in advisory's investment workflow time ?? Core Capabilities??? AlphaCopilot? introduces two groundbreaking solutions: ??Agentic Chief Investment Officer (ACIO):?Revolutionizing research, portfolio strategy, risk analytics, and client experiences. ?? Agentic Financial Advisor (AFA):?Delivering sophisticated tax-smart solutions across public and private markets?enabling cross-asset tax-alpha?through intelligent harvesting strategies. Powered by Linvest21's patented?AI-Engineer Platform (AIE), AlphaCopilot? is thoughtfully designed to address the sophisticated needs of hedge funds, asset managers, and financial advisors. ?? Strategic Partnerships??? Leading hedge funds, asset and wealth management firms are already exploring AlphaCopilot?'s transformative potential across multi-asset strategies and comprehensive investment capabilities through our?Early Access Program. ???What's Next??? In the coming weeks, we'll unveil additional components that further enhance AlphaCopilot?, cementing its position as the premier agentic investment platform in the industry. ?? Exclusive Early Access Program for Investment Leaders??? Ready to transform your investment approach??Join other forward-thinking institutions in our?Early Access Program?and help redefine what's possible. Designed specifically for CIOs and CEOs of asset and wealth management firms seeking competitive advantage. For detailed information about AlphaCopilot? Beta 1.0 and to apply for the Early Access Program, visit?https://lnkd.in/eTp3iBGr?or?https://linvest21.ai/ #AlphaCopilot #Linvest21 #InvestmentInnovation #AIFinance #FinTech #AssetManagement

Universal Quantum x AIST – Advancing Scalable Quantum Computing in Japan We've signed an MoU with AIST and G-QuAT to drive the development of a truly scalable trapped-ion quantum computing solution, reinforcing Japan’s position as a global leader in quantum technology. Excited to push the boundaries of quantum innovation together! Read the full press release below #QuantumComputing #DeepTech #Innovation #JapanTech #QuantumEcosystem

Big news! ?? The DreamFlare mobile app is here, bringing the most innovative AI-powered creators and content straight to your fingertips. Now, fans everywhere can seamlessly explore, engage, and experience the future of entertainment—anytime, anywhere. Ready to dive in? Download Dreamflare today and be part of what’s next! #Dreamflare #AIContent #ArtificialIntelligence #Innovation #FutureOfEntertainment www.dreamflare.ai

TICK tock. Your Immune clock is ticking! -Immune Age- Omniscope is launching a suite of Immune Tracking products at #MWC2025. Our -Immune Age- leverages T cells as a living sensors to sense and memorize systemic challenges. Pathogen exposure, for instance, triggers an immune response that leaves a lasting imprint on the T cell repertoire. However, we found that the signals encoded in T cell receptor (TCR) sequences extend far beyond infections. They carry quantifiable insights into stress, internal and external load, and, ultimately, biological aging. Omniscope, together with FC Barcelona, now applies the potential of T cell sequencing as a Diagnostic tool to define Health, to optimize Performance and to avoid Injuries. Our T Cell Clock is a dynamic measure to quantify the accumulation of a player's load and the success of targeted interventions. No doubt, our -Immune Age- application will go beyond the area of sports, to better define health and to extend healthy aging (Health span). Our T cell sensor approach provides a new Biomarker strategy to quantify #BiologicalAge, complementing the more static Methylation clocks (Eric Topol, MD: https://lnkd.in/d9PXnfdk). Excited to see -Immune Age- to be applied in additional health intervention studies. Please reach out to collaborate! #HealthyAging #Longevity

?? New research from our scientific co-founder, Dr. Li-Huei Tsai at The Picower Institute for Learning and Memory, reinforces the power of gamma stimulation for #brainhealth. A growing body of evidence shows that sensory stimulation using light and sound at 40Hz can enhance neural function and resilience. In Dr. Tsai’s latest review paper, findings highlight how this non-invasive approach can: ?? Reduce neuroinflammation ?? Improve blood flow ?? Strengthen neural connectivity This research is paving the way for a new era in neurodegenerative disease treatment—one that moves beyond traditional drug-based approaches. Read more: https://lnkd.in/eKqCf3gf #Neuroscience #BrainHealth #Alzheimers #Innovation

We’re so proud to announce that Salt Security has been named on The Channel Company's 10th annual Security 100 list in the Web, Email, and Application Security category ???? More information here: https://lnkd.in/eJeFdR9Y Check it out on CRN’s site here: https://lnkd.in/eEQdTQfV #cybersecurity #CRN #Security100 #apisecurity

STAMP on STAGE! ?? Single-Cell Genomics without Sequencing. Extremely cheap profiling of MILLIONS of cells or HUNDREDS of samples with STAMP (Single-Cell Transcriptomics Analysis and Multimodal Profiling through Imaging). ?? NOW avaliable at Omniscope. Reach out to get more info: [email protected]? ? Read more here: https://lnkd.in/d4e86VWc Congratulations to the entire STAMP team Luciano G. Martelotto and Jasmine Plummer labs and to all my team at Centro Nacional de Análisis Genómico (CNAG)! On stage: Joe Beechem at #AGBT25 from Bruker presenting our STAMP with full-transcriptome + TCR data run on the #CosMx! ??

Citeline’s SCRIP Asks column spoke with our CEO Christian Howell for his predictions on what’s next for Alzheimer’s Disease development in 2025: “I anticipate a significant focus on novel therapies that go beyond antibody-based approaches. As current antibody therapies have shown limitations, particularly with brain inflammation, the focus will shift towards innovative solutions that offer both efficacy and safety,” said Christian Howell, CEO of Cognito Therapeutics. Read the article: https://lnkd.in/dSyX8Mmu

Our mental health system is broken. Here's some thoughts on how we can fix it. I’m grateful to Behavioral Health Tech for publishing my article on why delivering truly high-quality mental healthcare requires a holistic and measurement-based approach.

Cognito Therapeutics at the 6th Bioelectronic Medicine (BEM) Summit: Shaping the Future of #Neurotechnology We’re proud to sponsor The Sixth BEM Summit: Neurotechnologies for Individuals and Communities, a global forum highlighting bioelectronic medicine as a transformative platform for #healthcare, #technology, and #science. ?? Keynote Address: Dr. Ralph Kern, Chief Medical Officer, Cognito Therapeutics, Inc. ?? March 5, 2025 | ?? 8:45 - 9:45 AM ET Our CEO, Christian Howell, will also be in attendance as we discuss the future of non-invasive #neurotechnology and their impact on brain health. Join us as we explore how we're driving innovation in neurodegenerative disease treatment. ?? https://lnkd.in/eXEcF_RJ #BioelectronicMedicine #Neurotech #BrainHealth #Innovation #CognitoTherapeutics